Caplyta phase 3 data show rapid, significant mania symptom relief in bipolar I by day 3, sustained to week 3, with tolerable adverse effects.
|Slideshows|February 3, 2021
How to Screen for Bipolar Disorder in 2 Minutes
Author(s)Chris Aiken, MD
A new test screens for bipolar disorder with respectable accuracy
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Interventional Options for TRD: ECT, TMS, and Esketamine
2
Defining Treatment-Resistant Depression In Adults
3
AI as a Task-Replacing Tool for Psychiatric Care: A Conversation With Christoph Correll, MD
4
Closing the Diagnostic Gap in Dementia With Blood-Based Biomarkers
5